M. Diez Garcia - Medical Oncology Department, Vall d'Hebron University Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

O-5 Integrating Trastuzumab (T), with or Without Pertuzumab (P), into Perioperative Chemotherapy (CT) of HER-2+ Gastric Cancer (GC) - Subgroup Analyses of EORTC 1203 “INNOVATION”, a Collaboration with KCSG and DUCG

A. Wagner,H. Grabsch,M. Mauer,S. Lorenzen,O. Bouché, P. Thuss-Patience,A. Elme,M. Moehler,U. Fumagalli Romario,Y. Kang,G. Folprecht,U. Martens,M. Galán Guzmán,M. Ducreux,M. Díez García,G. Piessen,M. Collienne,F. Lordick

Annals of Oncology (2023): S182-S182

引用0浏览0引用

P-189 Surrogate endpoints in advanced gastroesophageal cancer: A systematic review and meta-analysis of phase III clinical trials

J. Veas, A. Prieto, M. Bonet,M. Díez García,A. Salud,R. Montal

Annals of Oncology (2023): S83-S83

引用0浏览0引用

Gastroesophageal adenocarcinoma in young adults: Retrospective analysis of clinical and molecular features

D. A. Acosta Eyzaguirre,G. Castillo,S. Vega, S. A. Bueno Salazar,A. Carmona, A. Vazquez,S. Landolfi,S. Aguilar Izquierdo,A. Vivancos,M. Diez Garcia,T. Macarulla

ANNALS OF ONCOLOGY (2023): S881-S882

引用0浏览0引用

P-53 A Phase 2, Multi-Center, Open-Label Study of Cinrebafusp Alfa (PRS-343) in Patients with HER2-high and HER2-low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Geoffrey Y. Ku,S. A. Piha-Paul, Mukul Gupta,Dong Yoon Oh, Y. Kim, J. Lee,S. Y. Rha, Young-Seok Kang,M. Díez García,Tania Fleitas Kanonnikoff,Virginia Arrazubi,Kayti Aviano,Tim Demuth

Annals of oncology (2022): S265-S265

引用0浏览0引用

CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

F. M. Esposito, J. Lee,S. Y. Rha,K. D. Penkov, A. Moisseev,M. Van den Eynde,H. Prenen,M. Diez Garcia,M. Gumus,T. Sagawa,M. Nechaeva, T. Kajiwara,H. Harputluoglu,L. Charbonnier,S. Bensfia, N. Yang, D-Y. Oh

ANNALS OF ONCOLOGY（2022）

引用0浏览0引用

P-285 Q-TWiST Analysis for Pembrolizumab Plus Chemotherapy Versus Chemotherapy As First-Line Treatment for Patients with Advanced Esophageal Cancer in the KEYNOTE-590 Study

M. Diez Garcia,S. Shah,S. Joo,A. Valderrama, S. Zhang, Y. Zhang,P. Enzinger

Annals of Oncology（2022）

引用0浏览0引用

SO-7 Co-occurring HER2 and PD-L1 Expression in Patients with HER2-positive Trastuzumab-Refractory Gastric Cancer (gc)/gastroesophageal Junction Adenocarcinoma (GEJA): Biomarker Analysis from the Trastuzumab Deruxtecan (T-Dxd) DESTINY-Gastric03 Trial

Y. Y. Janjigian,S. Y. Rha,Dong Yoon Oh,M. Díez García,H.W.M. van Laarhoven,Yun‐Ting Chao,Martina Di Bartolomeo,N. Haj Mohammad, Wenyan Zhong,Elizabeth Croydon,Fabiola Cecchi, J. Lee

Annals of oncology（2022）

引用5浏览0引用

1261Tip CARMEN-GC01: Phase II, Open-Label, Single-Arm Study of Tusamitamab Ravtansine in Combination with Ramucirumab in Pretreated Patients with Gastric or Gastroesophageal Junction Adenocarcinoma (GA/GEJA)

F.M. Esposito, J. Lee,S.Y. Rha,K.D. Penkov, A. Moisseev,M. Van Den Eynde,H. Prenen,M. Díez García,M. Gumus,T. Sagawa,M. Nechaeva, T. Kajiwara,H. Harputluoglu,L. Charbonnier,S. Bensfia, N. Yang, D-Y. Oh

Annals of oncology (2022): S1124-S1124

引用0浏览0引用

P-53 A phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in patients with HER2-high and HER2-low gastric or gastroesophageal junction (GEJ) adenocarcinoma

G. Ku,S. Piha-Paul,M. Gupta,D. Oh, Y. Kim, J. Lee,S. Rha,Y. Kang,M. Diez Garcia,T. Fleitas Kanonnikoff,V. Arrazubi,K. Aviano,T. Demuth

Annals of Oncology（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn